Abbott awards Austin-based Silicon Labs awarded $23.25M in Texas CHIPS Act funding
According to Abbott's announcement, the funding will support the tech company's research and development operations in Austin and the construction of a new research lab to develop a platform for integrating artificial intelligence.
Austin's Silicon Labs gets $23M Texas grant for semiconductor R&D
AUSTIN, Texas — Austin’s Silicon Laboratories has received a $23.3 million grant from the Texas Semiconductor Innovation Fund (TSIF), Gov. Greg Abbott announced on Wednesday. The grant will help fund new research and development and is expected to create more than $80 million in capital investment.
Silicon Labs awarded $23M grant from TSIF
Silicon Labs (SLAB) “announced the award of a $23 million grant from the Texas Semiconductor Innovation Fund established by the Texas CHIPS
Austin semiconductor operation receives $23M grant
Silicon Labs, an Austin-based semiconductor manufacturing company, recently received a Texas Semiconductor Innovation Fund grant of $23,250,000.
Silicon Labs wins Texas CHIPS Act funds to expand here
Silicon Labs, a fabless semiconductor company based in Austin, has been awarded a grant from the Texas Semiconductor Innovation Fund — part of the Texas CHIPS Act — to support its expansion in Central Texas.
Texas CHIPS Act Awards Silicon Labs $23 Million to Expand R&D Advancements in Austin
Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, today announced the award of a $23 million grant from the Texas Semiconductor Innovation Fund (TSIF) established by the Texas CHIPS Act.
Abbott Laboratories stock underperforms Wednesday when compared to competitors despite daily gains
Shares of Abbott Laboratories ABT rallied 1.50% to $132.13 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.24% to ...
If You Invested $10,000 In Abbott Laboratories Stock 10 Years Ago, How Much Would You Have Now?
Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report ...
Abbott Laboratories (NYSE:ABT) Lowered to Buy Rating by StockNews.com
Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...
Jim Cramer on Abbott Laboratories (ABT): “This Verdict Is an Outrage” – Wall Street Agrees?
His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...
Yahoo13d
Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility
Nvidia Stock Is Doing Something It's Only Done Twice Before in the Past 4 Years. History Says This Will Happen Next.
ETF Daily News10d
Analysts Set Abbott Laboratories (NYSE:ABT) Target Price at $133.06
Abbott Laboratories (NYSE:ABT – Get Free Report) has earned an average rating of “Moderate Buy” from the eighteen ratings firms that are presently covering the company, MarketBeat.com reports.
Convenience Store News2d
Abbott’s A-Plus Ambitions
On foodservice, Abbott’s offers two other brands: Hunt Brothers Pizza and its own Supremo Tacos. Another potential ...